STOCK TITAN

Novaccess Global Inc - XSNX STOCK NEWS

Welcome to our dedicated news page for Novaccess Global (Ticker: XSNX), a resource for investors and traders seeking the latest updates and insights on Novaccess Global.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Novaccess Global's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Novaccess Global's position in the market.

Rhea-AI Summary
NovAccess Global Inc. (XSNX) updates on business developments, financing, and annual meeting. A $10.7 million financing transaction with Sumner Global LLC is pending. Interim working capital provided by AJB Capital Investments, LLC. Fiscal 2023 annual report and Q1 2024 financial results filed with the SEC. Virtual Annual Meeting of Shareholders scheduled for May 6th, 2024. Dr. Dwain K. Irvin and Dr. Christopher Wheeler to present at the World Brain Mapping Foundation Annual World Congress in March 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
NovAccess Global Inc. (XSNX) secures $10.7 million financing from Sumner Global LLC to develop cancer immunotherapies for brain tumor patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
39.3%
Tags
none
-
Rhea-AI Summary
NovAccess Global Inc. (OTCQB: XSNX) will be presenting at the December 7th, 2023 virtual Investor Summit. The conference is completely complimentary to qualified investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
NovAccess Global Inc. (OTCQB:XSNX) appoints Dr. Roscoe M. Moore, Jr. to its Scientific Advisory Board, aiming to leverage his expertise for government funding and international collaborations in the development of personalized cancer immunotherapies for brain tumor patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.14%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
partnership
-
Rhea-AI Summary
NovAccess Global Inc. CEO to Participate in Glioblastoma Awareness Day
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.09%
Tags
partnership AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.91%
Tags
none
Novaccess Global Inc

OTC:XSNX

XSNX Rankings

XSNX Stock Data

571.46k
16.86M
58.14%
7.03%
Unlaminated Plastics Film and Sheet (except Packaging) Manufacturing
Manufacturing
Link
United States
Chagrin Falls